Pharmaceutical Resources Inc. PRX

On PlainSite Chat

No one has posted about Pharmaceutical Resources Inc. yet.

Share something about Pharmaceutical Resources Inc.:

An active PlainSite Pro or Pro Se subscription is required to view the Activity Timeline.

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (14)

	Last Name	First Name	Middle Name	Firm	Location
	Achkar	Charles	A.	Ostrolenk Faber LLP	New York, NY
	Barbour	Elizabeth	L.	Stack & O'Connor Chartered	CHICAGO, IL
	Brown	Loren	H.	Gray, Cary, Ware & Freidenrich, LLP	New York, NY
	Calmann	Arnold	B.	Saiber Schlesinger Satz & Goldstein, LLC	Newark, NJ
	Dougherty	John	Fitzgerald	Kramon & Graham, PA	Baltimore, MD
	Filpi	Robert	A.	Stack & Filipi, Chartered	CHICAGO, IL
	Fineman	Steven	J.	Richards, Layton & Finger, PA	Wilmington, DE
	GRASSOTTI	RINA		quicknet.nl Law Firm Placeholder	Florham Park, NJ
	LIEB	STEPHEN		Frommer Lawrence & Haug LLP
	Marbury	Hugh	Jewett	Cozen O'Connor, PC	EAST PALO ALTO, CA
	Mathis	Cori	A.	Law Offices of Marc J. Lane	Chicago, IL
	Murphy	Kevin	F.	Frommer Lawrence & Haug LLP
	Soos	Jeffrey	S.	Saiber Schlesinger Satz & Goldstein, LLC
	Stack	Paul	F.	Stack & Filipi, Chartered	Chicago, IL

Insider Trading History

SEC Filings

Filter By Form All Records 10-K 10-K/A 10-K405 10-K405/A 10-Q 10-Q/A 15-12G 25-NSE 3 3/A 4 4/A 424B3 8-A12B 8-B12B/A 8-K 8-K/A CERTNYS CORRESP CT ORDER DEF 14A DEFA14A DEFM14A EFFECT NT 10-K NT 10-Q NT 10-Q/A POS AM PRE 14A PREM14A PRER14A RW S-3 S-3/A S-4 S-8 S-8 POS SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A UPLOAD From To

	Date	Entity	Form Number	Description	Value
	9/21/2015		8-K	Current report pursuant to Section 13 or 15(d)
	8/6/2015		10-Q	Quarterly report pursuant to Section 13 or 15(d)
	5/11/2015		10-Q	Quarterly report pursuant to Section 13 or 15(d)
	3/13/2015		10-K	Annual report pursuant to Section 13 or 15(d)
	2/25/2015		8-K	Current report pursuant to Section 13 or 15(d)
	2/10/2015		8-K	Current report pursuant to Section 13 or 15(d)
	11/12/2014		10-Q	Quarterly report pursuant to Section 13 or 15(d)
	9/22/2014		8-K	Current report pursuant to Section 13 or 15(d)
	8/11/2014		10-Q	Quarterly report pursuant to Section 13 or 15(d)
	5/15/2014		10-Q	Quarterly report pursuant to Section 13 or 15(d)
	3/18/2014		10-K	Annual report pursuant to Section 13 or 15(d)
	2/20/2014		8-K	Current report pursuant to Section 13 or 15(d)
	2/19/2014		8-K	Current report pursuant to Section 13 or 15(d)
	1/29/2014		8-K	Current report pursuant to Section 13 or 15(d)
	1/21/2014		8-K	Current report pursuant to Section 13 or 15(d)
	11/12/2013		10-Q	Quarterly report pursuant to Section 13 or 15(d)
	8/27/2013		EFFECT
	8/27/2013		424B3	Prospectus under Securities Act Rule 424(b)(3)
	8/23/2013		CORRESP	Correspondence with SEC staff
	8/22/2013		UPLOAD	Upload of correspondence or documents
	8/22/2013		CORRESP	Correspondence with SEC staff
	8/14/2013		S-4	Registration statement for mergers and exchange offers
	2/11/2013		SC 13G/A	Amendment to statement of beneficial ownership (Schedule 13G)
	10/16/2012		15-12G	Suspension of reporting duty under Exchange Act Section 12(g)
	10/12/2012		15-12G	Suspension of reporting duty under Exchange Act Section 12(g)
	10/10/2012		SC 13G/A	Amendment to statement of beneficial ownership (Schedule 13G)
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/9/2012		S-8 POS	Post-effective amendment to S-8 registration statement
	10/5/2012		25-NSE	Notification of removal from listing on national securities exch...
	10/2/2012		8-K	Current report pursuant to Section 13 or 15(d)
	10/2/2012		8-K	Current report pursuant to Section 13 or 15(d)
	10/2/2012	Smith, Joseph E.	4	Statement of changes in beneficial ownership of securities
	10/2/2012	Knight Peter S	4	Statement of changes in beneficial ownership of securities
	10/2/2012		4	Statement of changes in beneficial ownership of securities
	10/2/2012	Rice Thomas P	4	Statement of changes in beneficial ownership of securities
	10/2/2012	Zenner Patrick J	4	Statement of changes in beneficial ownership of securities
	10/2/2012	Sharoky Melvin Md	4	Statement of changes in beneficial ownership of securities
	10/2/2012	Lepore Patrick G	4	Statement of changes in beneficial ownership of securities

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.

Corporate Family (5)

Track Corporate Family

• CR Intrinsic Investors, LLC, None
• Deerfield International Ltd., None
• Deerfield Partners LP, None
• SAC Capital Advisors, LLC, None
• SAC Capital Management, LLC, None

Subsidiaries

• Deerfield Partners LP
• Deerfield International Ltd.
• SAC Capital Management, LLC
• CR Intrinsic Investors, LLC
• SAC Capital Advisors, LLC

Sign in to add additional links.